The evaluation of Canine Atopic Dermatitis Extent and Severity Index (CADESI) test in dogs with Atopic Dermatitis (AD) treated with cyclosporine or prednisone
Divisions of PAS
Burton G. (2004), Efficacy of cyclosporin in the treatment of atopic dermatitis in dogs - combined results from two veterinary dermatology referral centres, Aust Vet J, 82, 681. ; Carlotti D. (2004), Use of recombinant omega interferon therapy in canine atopic dermatitis: a pilot study, Vet Dermatol, 15, 32. ; DeBoer D. (2001), The ACVD task force on canine atopic dermatitis (XV): Fundamental concepts in clinical diagnosis, Vet Immunol Immunopathol, 81, 271. ; Favrot C. (2010), Development of a questionnaire to assess the impact of atopic dermatitis on health-related quality of life of affected dogs and their owners, Vet Dermatol, 21, 63. ; Favrot C. (2010), A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis, Vet Dermatol, 21, 23. ; Germain P. (2005), CADESI (Canine Atopic Dermatitis Extent and Severity Index) reproducibility, Rev Med Vet-Toulouse, 156, 382. ; Gliński W. (2004), Diagnostic prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force on the national specialists on dermatology and venereology and allergology, Postep Derm Alergol, 21, 265. ; Kunz B. (1997), Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis, Dermatology, 195, 10. ; Marsella R. (2006), Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs, Vet Dermatol, 17, 24. ; Nesbitt G. (1978), Canine allergic inhalant dermatitis: a review of 230 cases, J Am Vet Med Assoc, 172, 55. ; Nesbitt G. (1984), Canine atopy.1. Etiology and diagnosis, Compendium on Continuing Education of Practicing Veterinarian, 6, 73. ; Olivry T. (1997), Treatment of canine atopic dermatitis with misoprostol, a prostaglandin E1 analogue: an open study, J Dermatol Treat, 8, 243. ; Olivry T. (2001), The American Collage of Veterinary Dermatology Task Force on Canine Atopic Dermatitis. ; Olivry T. (2002), Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial, Vet Dermatol, 13, 77. ; Olivry T. (2003), Evidence-based veterinary dermatology : a systematic review of pharmacotherapy of canine atopic dermatitis, Vet Dermatol, 14, 121. ; Olivry T. (2007), Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis, Vet Dermatol, 18, 78. ; Olivry T. (2008), Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis, Vet Dermatol, 19, 115. ; Prelaud P. (1998), Reevaluation of diagnostic criteria of canine atopic dermatitis, Rev Med Vet-Toulouse, 149, 1057. ; L Reedy (1997), Allergic skin diseases of dogs and cats. ; Scott D. (2001), Muller and Kirk's Small Animal Dermatology. ; Steffan J. (2003), Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel blinded, randomized controlled trial, Vet Dermatol, 14, 11. ; Steffan J. (2004), Remission of the clinical signs of atopic dermatitis in dogs after cessation of treatment with cyclosporin A or methylprednisolone, Vet Rec, 154, 681. ; Willemse A. (1984), Investigation of symptomatology and the significance of immediate skin test reactivity in canine atopic dermatitis, Res Vet Sci, 34, 261. ; Willemse A. (1986), Atopic skin disease: a review and a reconsideration of diagnostic criteria, J Small Anim Pract, 27, 771.